Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose.

Clinics (Sao Paulo) · 2023 · PMC9705212 · PMID 36529052

Europe PMC DOI

hedged sentence

0.0740

closest p · 1.5× alpha

0.0740

boldest claim

The sentences

did not reach statistical significancep = 0.074so close (0.05 < p ≤ 0.1)

Factors associated with seroconversion and NAb positivity among naïve-AAV patients at D69 Analyzing the possible impact of disease activity on the immunogenicity of the vaccine, the higher frequency of seroconversion rates at D69 in naïve AAV patients with BVAS activity score = 0 compared to those with BVAS > 0 did not reach statistical significance (74.2% vs. 41.7%, p = 0.074).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.